Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women
Completed · Phase 1
Conditions studied: Postmenopause
In brief
The purpose of the study is to evaluate the safety and efficacy of new tablet formulations of Premarin®/medroxyprogesterone (MPA).
Key facts
- Study ID
- NCT00543634
- Run by
- Wyeth is now a wholly owned subsidiary of Pfizer
- People needed
- 30
- Starts
- 2007-10-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2010-06-22
Who can join
Age: 35 and older, up to 70. Sex: female. Healthy volunteers: accepted.
Where it is running
- Study site — Omaha, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.